Companies · Other Health Care

American Nitrile Intermediate Holdings, LLC

GROVE CITY · Other Health Care

Diligence memoA one-page analyst read on American Nitrile Intermediate Holdings, LLC — recommendation, valuation, rhythm, risks.
$1.8M
Total raised · real
2
Rounds
1.3×
Latest step-up
Top 56%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Wed Sep 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

American Nitrile Intermediate Holdings, LLC looks over-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 4.07× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

American Nitrile Intermediate Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.3 yr record
Peak capital year was 2022 with $1.8M across 2 filings.
Market position
ahead of 45% of Other Health Care peers
Capital scale is ahead of 45% of Other Health Care peers; modeled value is above 35% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $1.8M across 2 filings.
  • Largest single filing was $1.0M on 2022-09-07.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

American Nitrile Intermediate Holdings, LLC is one of 5376 Other Health Care companies tracked from GROVE CITY. By capital raised it ranks mid-pack (ahead of 45% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2022
Year incorporated
2022-09-07
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2022-03-04 Raised $800K (real) Modeled valuation $11M (est)$800K$11MPre-Seed2022Pre-Seed · 2022-09-07 Raised $1.0M (real) Modeled valuation $10M (est)$1.0M$10MPre-Seed2022+$1.0MCumulative $1.8M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$800K · 2022
Pre-Seed extension$1.0M · 2022

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$10.4M
Base estimate est.
$627K
Conservative case
$60.8M
Upside case
$5.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $10.7M · 2022-03-042022Pre-Seed · modeled $10.4M · 2022-09-072022
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
3.8 yr
Elapsed time used
3.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$3.5M/yr
Capital velocity
4.3 yr
On record since
2022
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.7× of median
This company$1.8M
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 2.9× above median
This company$1.0M
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.5× of median
This company$10.4M
Sector median$22.1M

Raised more than 45% of sector peers (real $). Modeled value above 35% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #7 of 288.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Active Recovery TMS, LLC · Pre-Seed Raised $1.0M · modeled $14.1M (est)Imagen Walled Lake Support Services, LLC · Pre-Seed Raised $977K · modeled $12.9M (est)Pinnacle Integrated Medicine, Inc. · Pre-Seed Raised $2.3M · modeled $12.3M (est)Choix, Inc. · Pre-Seed Raised $1000K · modeled $12.2M (est)DataBiologics, Inc. · Pre-Seed Raised $815K · modeled $11.2M (est)DIAGGO, Inc. · Pre-Seed Raised $1.0M · modeled $11.1M (est)2636696 Ontario Inc. · Pre-Seed Raised $1.3M · modeled $9.9M (est)Exo-Toe, Llc · Pre-Seed Raised $1.2M · modeled $9.6M (est)RoddyMedical Holdings, Inc. · Pre-Seed Raised $915K · modeled $9.6M (est)Phoeb-X, Inc. · Pre-Seed Raised $912K · modeled $9.5M (est)NeuroGlove, LLC · Pre-Seed Raised $1.0M · modeled $9.1M (est)American Nitrile Intermediate Holdings, LLC (this company) Raised $1.8M · modeled $10.4M (est)American Nitrile Intermediate Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
Active Recovery TMS, LLCPre-Seed$1.0M$14.1M5.51×
Imagen Walled Lake Support Services, LLCPre-Seed$977K$12.9M5.05×
Pinnacle Integrated Medicine, Inc.Pre-Seed$2.3M$12.3M4.81×
Choix, Inc.Pre-Seed$1000K$12.2M4.78×
DataBiologics, Inc.Pre-Seed$815K$11.2M4.37×
DIAGGO, Inc.Pre-Seed$1.0M$11.1M4.35×
American Nitrile Intermediate Holdings, LLC this companyPre-Seed$1.8M$10.4M4.07×
2636696 Ontario Inc.Pre-Seed$1.3M$9.9M3.87×
Exo-Toe, LlcPre-Seed$1.2M$9.6M3.77×
RoddyMedical Holdings, Inc.Pre-Seed$915K$9.6M3.76×
Phoeb-X, Inc.Pre-Seed$912K$9.5M3.71×
NeuroGlove, LLCPre-Seed$1.0M$9.1M3.56×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$800K2022-03-04$4.4M$10.7M90%
Pre-Seed$1.0M2022-09-07$5.6M$10.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$800K2022-03-04
    • First recorded raise — entered as Pre-Seed.
    • 4 investors on this round.
  2. Pre-Seed$1.0M2022-09-07
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
Intelligence
2023 ~Q1
Modeled next raise · ~6mo cadence
$1.3M
Modeled next size est.range $1.0M$2.0M
1.3×
Last step-up
$3.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jacob L. Block1 other2022-03
Registry & provenance

American Nitrile Intermediate Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1916760
SEC CIK
2022
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
JDCQ Solutions, LLCOther Health CarePre-Seed$1.9M$12.3Msame sector · same stage
Arrayent Health, LLCOther Health CarePre-Seed$2.0M$12.3Msame sector · same stage
Healthpoint Services Global, Inc.Other Health CarePre-Seed$2.2M$9.2Msame sector · same stage
Pinnacle Integrated Medicine, Inc.Other Health CarePre-Seed$2.3M$12.3Msame sector · same stage
NuvoMed, Inc.Other Health CarePre-Seed$1.4M$12.0Msame sector · same stage
Norwalk Surgery Center, LLCOther Health CarePre-Seed$1.3M$9.6Msame sector · same stage
Patient Conversation Media, Inc.Other Health CarePre-Seed$1.3M$10.8Msame sector · same stage
2636696 Ontario Inc.Other Health CarePre-Seed$1.3M$9.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Nivati, Inc.Other Health CareSeed$2.4M83%
SYFS Intermediate Holdings, LLCOther Health CareSeries D+$4.3B82%
Nxt Biomedical, LlcOther Health CareSeries A$187.4M82%
Strayne Holdings, LlcOther Health CarePre-Seed$3.1M82%
Ark National Holdings LLCOther Health CareSeries A$83.0M82%
Assure Holdings Corp.Other Health CareSeries A$2.6M81%
National Cardiac Inc.Other Health CarePre-Seed$17.9M81%
New IVS Holdings, LLCOther Health CarePre-Seed$17.7M81%
Frequently asked
How much funding has American Nitrile Intermediate Holdings, LLC raised?
American Nitrile Intermediate Holdings, LLC has raised approximately $1.8M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is American Nitrile Intermediate Holdings, LLC's estimated valuation?
Provath's modeled valuation for American Nitrile Intermediate Holdings, LLC is approximately $10.4M (modeled range $627K–$60.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is American Nitrile Intermediate Holdings, LLC at?
American Nitrile Intermediate Holdings, LLC's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Wed Sep 07.
What does American Nitrile Intermediate Holdings, LLC do and where is it based?
American Nitrile Intermediate Holdings, LLC operates in the Other Health Care sector, based in GROVE CITY.
Explore related

See where American Nitrile Intermediate Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at American Nitrile Intermediate Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.